MNKD

Afrezza Could Push MannKind Shares Higher, Says 5-Star Analyst

Momentum is picking up for diabetes-focused biotech MannKind (MNKD). Shares surged 36% this week after MannKind’s presentation at the American Diabetes Association’s conference …

Smarter Team — June 19, 2020, 8:32 PM EDT

MannKind (MNKD) Stock Could Nearly Double in the Next Year, Says Analyst

It has been a rough five years for investors of diabetes-focused biotech MannKind (MNKD). Over the period, shares of the company have declined …

Marty Shtrubel — May 19, 2020, 8:44 PM EDT

3 Penny Stocks With Triple-Digit Upside Potential

Buckle up, we’re in for a bumpy ride. The number of new coronavirus (COVID-19) cases continues to surge, and as such, the market’s …

Maya Sasson — March 31, 2020, 10:50 AM EDT

3 Top-Notch “Strong Buy” Stocks Under $3

If you’re on a budget, yet in a risk-tolerant mood, it’s worth taking a look at penny stocks – companies whose shares sell …

Marty Shtrubel — January 20, 2020, 4:33 AM EDT

Analyst Thinks MannKind’s (MNKD) Afrezza Still Has a Shot, Though Q3 Earnings Hit Below Guidance

Despite MannKind (MNKD) reporting third-quarter revenue for diabetes drug Afrezza below H.C.

Shanna Fuld — November 7, 2018, 11:05 AM EDT

H.C. Wainwright Reiterates Buy on MannKind (MNKD) Stock as TreT Unveiled to Broader Audience at United’s Science Day

Yesterday, United Therapeutics (UTHR), MannKind’s (MNKD) partner for Technosphere treprostinil (TreT), hosted its Science Day 2018. MannKind’s dry powder inhalable treprostinil formulation for …

Jason Cohen — September 25, 2018, 12:34 PM EDT

H.C. Wainwright Reiterates Upbeat View of MannKind; Here’s Why

This week, MannKind (MNKD) announced a global partnership with United Therapeutics (UTHR) to develop and commercialize Technosphere treprostinil (TreT) dry powder inhalation for …

Jason Cohen — September 7, 2018, 1:36 PM EDT